Post Approval Study of the CyPass System
Public ClinicalTrials.gov record NCT03273907. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Post Approval Study of the CyPass System in Patients With Primary Open Angle Glaucoma Undergoing Cataract Surgery
Study identification
- NCT ID
- NCT03273907
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Not applicable
- Lead sponsor
- Alcon Research
- Industry
- Enrollment
- 79 participants
Conditions and interventions
Conditions
Interventions
- CyPass Micro-Stent implanted with CyPass 241-S applier Device
- Cataract surgery Procedure
Device · Procedure
Eligibility (public fields only)
- Age range
- 45 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Oct 11, 2017
- Primary completion
- Aug 30, 2021
- Completion
- Aug 30, 2021
- Last update posted
- Feb 15, 2024
2017 – 2021
United States locations
- U.S. sites
- 20
- U.S. states
- 13
- U.S. cities
- 19
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Alcon Investigative Site | Phoenix | Arizona | 85016 | — |
| Alcon Investigative Site | Orange | California | 92868 | — |
| Alcon Investigative Site | Fort Collins | Colorado | 80528 | — |
| Alcon Investigative Site | Jacksonville | Florida | 32256 | — |
| Alcon Investigative Site | Panama City | Florida | 32405 | — |
| Alcon Investigative Site | Gainesville | Georgia | 30501 | — |
| Alcon Investigative Site | Marietta | Georgia | 30060 | — |
| Alcon Investigative Site | Garden City | Kansas | 67846 | — |
| Alcon Investigative Site | Fraser | Michigan | 48026 | — |
| Alcon Investigative Site | St Louis | Missouri | 63131 | — |
| Alcon Investivative Site | St Louis | Missouri | 63141 | — |
| Alcon Investigative Site | Vineland | New Jersey | 08361 | — |
| Alcon Investigative Site | Bala-Cynwyd | Pennsylvania | 19004 | — |
| Alcon Investigative Site | Chambersburg | Pennsylvania | 17201 | — |
| Alcon Investigative Site | Austin | Texas | 78731 | — |
| Alcon Investigative Site | El Paso | Texas | 79902 | — |
| Alcon Investigative Site | Houston | Texas | 77030 | — |
| Alcon Investigative Site | Bellevue | Washington | 98004-3012 | — |
| Alcon Investigative Site | Kenosha | Wisconsin | 53142 | — |
| Alcon Investigative Site | Racine | Wisconsin | 53405 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT03273907, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Feb 15, 2024 · Synced Jul 23, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT03273907 live on ClinicalTrials.gov.